Human Menopausal Gonadotrophin (HMG)
Pharmaceutical Procurement & Formulation Integration
Product Overview
HMG (Human Menopausal Gonadotrophin) is a clinically established peptide hormone used in reproductive medicine to support controlled ovarian stimulation and follicular development. Rather than presenting high-level pharmacology, this page focuses on the aspects that matter in pharmaceutical procurement and formulation integration - consistency across batches, traceability of results, and documentation supporting regulatory review.
This HMG API is manufactured with controlled processes and tested against strict acceptance criteria. It is intended for use in drug formulation programs, analytical method development, and quality assessment rather than direct administration.
Identity, Specifications & Storage
- ▸ Product Name: Human Menopausal Gonadotrophin (HMG)
- ▸ CAS Number: 61489-09-8
- ▸ Physical Form: White to off-white lyophilized powder
- ▸ Purity: ≥ 98% (HPLC verified per lot)
- ▸ Solubility: Designed to reconstitute in validated buffer systems
- ▸ Storage: Short-term: 2–8 °C; Long-term: -20 °C preferred; Protect from moisture/light
Each manufacturing lot undergoes analytical verification for identity and purity before release.
Quality & Documentation
Achieving consistency is essential for regulated development. Every batch of HMG API is accompanied by comprehensive batch documentation that supports internal quality control and regulatory work:
- ▸ Certificate of Analysis (COA): With assay and impurity data
- ▸ Material Safety Data Sheet (MSDS)
- ▸ Technical Data Sheet (TDS): With handling notes
- ▸ Impurity and stability summaries
Providing numerical assay results and impurity profiles enables QC teams to accept incoming material efficiently.
Practical Laboratory Integration
Scientists and analysts typically focus on these pragmatic aspects:
- ▸ Chromatographic Consistency: HPLC profiles are compared against historical reference data.
- ▸ Activity vs. Purity Balance: Measured by potency and verified purity benchmarks.
- ▸ Buffer Compatibility Mapping: Establishing reconstitution media before scaling.
Handling & Stability Framework
- ▸ Conditioning: Allow sealed vials to stabilize at working temperature before opening.
- ▸ Resealing Protocol: Only open under controlled humidity; reseal residual material immediately.
- ▸ Aseptic Reconstitution: Perform under sterile conditions using validated buffers.
Packaging & Supply Logistics
- ▸ Primary Packaging: Moisture-barrier glass vials with desiccant.
- ▸ Traceability Labels: Batch and lot identifiers suitable for ERP/LIMS systems.
- ▸ Shipping Options: Controlled temperature transport available upon request.
Procurement Pathway
- ▸ Evaluation Phase: Sample orders for analytical matching and stability screening.
- ▸ Qualification Phase: Review of COA/Impurity data against internal benchmarks.
- ▸ Scale Phase: Transition into bulk supply once performance is confirmed.
Operational FAQ
Q: Is this product supplied as a finished drug?
A: No. HMG API is delivered strictly as a pharmaceutical intermediate for use in formulation and manufacturing.
Q: How should this API be stored long-term?
A: Store sealed and dry; short-term at 2–8 °C; long-term at -20 °C with protection from moisture and light.
Q: Are custom packaging options supported?
A: Yes - packaging and labeling can be tailored to specific regulatory or process requirements.
Operational Excellence
Focusing on quantitative QC criteria and operational practice details to help teams qualify material and minimize development cycles.
Hot Tags: hmg human menopausal gonadotrophin cas 61489-71-2, China hmg human menopausal gonadotrophin cas 61489-71-2 manufacturers, suppliers, factory, Carbetocina Humana, Human Oxytocin, 74381-53-6, Atosiban Acetate, Acetato de terlipresina, Gonadotropina Menop usica Humana
